In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

The new oral medication, daraxonrasib, has been shown to meaningfully extend the lives of patients with late-stage pancreatic ...

A common blood pressure drug may help a major class of cancer therapies work far better than expected. A widely prescribed ...

For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are ...

Exclusive: After the devastating news of a terminal cancer diagnosis, Debbie Rhodes and her husband Randy were delivered a ...

A new Phase I clinical trial provides proof of concept for a potential therapy for treatment-resistant cancers, particularly ...

A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those ...

Medications are designed to treat diseased tissues while sparing healthy ones, often by attaching the drug to something that helps guide it directly to its target. But drugs also need time to work, ...

Revolution Medicines while they await what they hope will be a speedy FDA approval. The Food and Drug Administration allowed the expanded access ‌program on May 1, less than three weeks after ...

BeOne Medicines said on Wednesday that ​the U.S. Food and Drug ‌Administration has approved its drug for a type of blood ​cancer.